Bio-Works Technologies AB publishes Business Update ahead of next value creation phase

Bio-Works Technologies AB (“Bio-Works” or the “Company”) hereby publishes an operational and financial update in connection with a meeting with investors conducted by the Company’s management and Board of Directors on Friday, March 6.

The information is such that Bio-Works is obliged to disclose pursuant to the EU Market Abuse Regulation (MAR).

The Company reports continued progress in line with its previously communicated strategy, with improved financial performance, strengthened commercial activity, and a fully funded plan through to break-even.
Commercial Development

A key